Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Assets: 2018-2025

  • Dr Reddys Laboratories' Current Assets fell 1.61% to $2.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.9 billion, marking a year-over-year decrease of 1.61%. This contributed to the annual value of $2.9 billion for FY2025, which is 1.61% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Current Assets of $2.9 billion as of Q1 2025, which was down 1.61% from $3.0 billion recorded in Q1 2024.
  • In the past 5 years, Dr Reddys Laboratories' Current Assets registered a high of $3.0 billion during Q1 2024, and its lowest value of $2.0 billion during Q1 2021.
  • Its 3-year average for Current Assets is $2.8 billion, with a median of $2.9 billion in 2025.
  • Per our database at Business Quant, Dr Reddys Laboratories' Current Assets increased by 18.25% in 2022 and then declined by 1.61% in 2025.
  • Quarterly analysis of 5 years shows Dr Reddys Laboratories' Current Assets stood at $2.0 billion in 2021, then climbed by 18.25% to $2.4 billion in 2022, then rose by 5.05% to $2.5 billion in 2023, then increased by 18.19% to $3.0 billion in 2024, then dropped by 1.61% to $2.9 billion in 2025.
  • Its Current Assets was $2.9 billion in Q1 2025, compared to $3.0 billion in Q1 2024 and $2.5 billion in Q1 2023.